Cytochrome P450 Genotyping for Pain Management Medications

Date: Thursday, July 05, 2012

Author: McClure, F. Leland, MSci, PhD
Director, Pain Management
Quest Diagnostics
St. Louis, MO  
Also By This Author

Category: CE Credit, Webinar

Description: Leland McClure, MSci, PhD, discusses how variations in DNA coding of the cytochrome P450 family of enzymes can affect the rate and extent of drug metabolism and influence a patient's response to pain management medications – critical information for healthcare providers prescribing opioids to their patients for pain management.

Learning objectives - at the conclusion of this program participants will be able to:

• Discuss how variations in DNA coding of the cytochrome P450 family of enzymes can affect the rate and extent of drug metabolism
• Describe how genetic differences may influence a patient's response to pain management medications
• Communicate how cytochrome P450 test results may help physicians to develop a treatment strategy for patients using pain management medications
• Conclude how and when to use cytochrome P450 test for pain management